… on Lung Cancer hosted by the International Association for the Study of Lung Cancer … unresectable, Stage III non-small cell lung cancer following chemoradiation therapy. Today’s announcement … patients with NSCLC, small cell lung cancer, locally-advanced or metastatic urothelial carcinoma …

… new standard treatment for mid-stage lung cancer patients whose diseases has not … data in locally-advanced, non-small cell lung cancer (NSCLC) patients whose tumours cannot … been around 15% after concurrent chemoradiation therapy. The significant survival benefit …

… presented data that showed its lung cancer treatment Imfinzi significantly improved patient … on Lung Cancer hosted by the International Association for the Study of Lung Cancer … unresectable, Stage III non-small cell lung cancer following chemoradiation therapy,' chief medical …

Women diagnosed with non-small cell lung cancers (NSCLC) live longer than their … of Lung Cancer's (IASLC's) 19th World Conference on Lung Cancer … for women." Explore further: Chemoradiation in elderly patients with stage …

… marketing authorisation for a new lung cancer treatment. Imfinzi was for the … of locally-advanced, unresectable non-small cell lung cancer in adults whose disease had … to having a treatment following chemoradiation therapy,' chief medical officer …

… unresectable stage III non-small cell lung cancer (NSCLC). The phase III pacific … has not progressed after platinum-based chemoradiation therapy. It is being assessed … in this earlier stage of lung cancer. “We look forward to sharing …

… unresectable Stage III non-small cell lung cancer (NSCLC) whose disease had not … in this earlier stage of lung cancer. We look forward to sharing … had not progressed following platinum-based chemoradiation therapy and under regulatory review …

… stage III non-small cell lung cancer (NSCLC) whose tumors are … with chemotherapy and radiation (chemoradiation). “This is the … to prevent progression is chemoradiation. Although a small … a longer time after chemoradiation.” Lung cancer is the leading cause …

… stage III non-small cell lung cancer whose tumors are not … For patients with stage III lung cancer that cannot be removed … to prevent progression is chemoradiation. Although a small number … a longer time after chemoradiation.” Lung cancer is the leading cause …

… stage III non-small cell lung cancer (NSCLC) whose tumors are … with chemotherapy and radiation (chemoradiation). “This is the … to prevent progression is chemoradiation. Although a small … a longer time after chemoradiation.” Lung cancer is the leading cause …